Bring together
world's leading experts

Aritz, CEO of Resolve Stroke, is a seasoned professional with over 7 years of experience in Healthcare, Tech, and Private Equity support. Prior to founding Resolve Stroke, he was a valued member of the Roland Berger Healthcare global core team, a key strategy consulting firm. Aritz brings a unique blend of skills and knowledge to drive Resolve Stroke. Aritz’s expertise stems from his cross-disciplinary academic background, with degrees in Medical Sciences from Imperial College London, Business from HEC Paris, and Engineering from CentraleSupélec.

Vincent is a renouned expert in biomedical ultrasounds and a pioneer in software-driven ultrasound methods. He co-founded Resolve Stroke after close to ten years in world class laboratories including as a visiting researcher at Harvard University, USA, co-writing more than twenty papers and four patents. Vincent brings a solid technical expertise from his academic background and original engineering degree from ESPCI. He brings his experience of conducting clinical research and a solid network of clinicians.

CNRS Research Director, team leader at the Biomedical Imaging Laboratory (Sorbonne Université, CNRS, INSERM), Paris, France

Olivier Couture is a distinguished figure in the field of medical imaging and ultrasound technology. With a deep expertise in non-invasive diagnostic techniques, he has significantly contributed to advancing the accuracy and efficacy of ultrasound diagnostics with several scientific publications for instance in Nature.

Pr. Anthony Samir is a Professor at Harvard Medical School, and a Diagnostic and Interventional Radiologist at the Massachusetts General Hospital, where he serves as Service Chief for Body Ultrasound Imaging Services. He has an extensive clinical leadership experience in a high-volume service comprising 50 technologists at 10 sites read by ~110 radiologists. He is a serial inventor, with five inventor’s prizes for medical devices and multiple patents. With his internationally recognized expertise in quantitative biomarker development, medical devices, applied machine learning, ultrasound, cancer, liver disease, and thyroid disease, he is a key asset for Resolve Stroke. As Resolve Stroke’s advisor, he brings his extensive experience with technology transition to industry and with executing at multiple levels: entrepreneur, board roles.

François Tranquart, MD, PhD, is a globally recognized leader with deep expertise in medical imaging and clinical development. He formerly served as Global Head of Clinical Development at GE Healthcare and was previously General Manager at Bracco Suisse. In these roles, he led worldwide clinical programs across oncology, cardiovascular imaging, and molecular diagnostics.
A pioneer in contrast-enhanced ultrasound, François played a key role in the development of cutting-edge technologies.
He serves as a trusted advisor to organizations at the forefront of imaging technology, clinical validation, and market access.

Brian McEathron was General Manager, General Imaging Ultrasound at General Electric HealthCare division. Brian brings an experience of +24 years in marketing, sales, and customer applications. He has in depth knowledge of the healthcare issues and disparities that exist. He led global teams from engineering, and manufacturing at GE Health Care division. He has worked very closely with the top healthcare providers from around the globe.

Sylvain Bodard currently conducts clinical research at Memorial Sloan Kettering in New York and Harvard University in Boston, US. He is a Clinical Fellow at Necker Hospital, Paris Cité University in Paris, France. In this role, he performs and supervises scheduled and on-call image-guided interventional radiology procedures for both inpatients and outpatients. His responsibilities include patient triage and admission, as well as the protocol/readout of diagnostic x-ray, computed tomography, and magnetic resonance imaging studies. His previous research in France (Sorbonne University, CNRS, INSERM, LIB, SMAER, Paris) and today in the US focuses on advancing medical imaging techniques and furthering the understanding and treatment of various medical conditions.

Vivien Szabo, Anesthesiologist and Researcher in the department of Anesthesiology and Critical Care Medicine at Montpellier University Hospital (France) combines his medical practice with cutting-edge research in neuroscience. After training at the medical school of Montpellier, he joined the Inserm Liliane Bettencourt School – MD-PhD program, where he mastered cellular biology and BRET microscopy. His doctoral studies in Serge Charpak’s laboratory led to significant advancements in simultaneous calcium imaging and photoactivation with cellular resolution. Now, as part of Julie Perroy’s team, he continues to develop innovative in vivo microscopy techniques to investigate physiological and pathological synaptic transmission. His unique blend of clinical practice and research makes him a valuable contributor to the field of neuroscience.

David, who co-founded Implicity with Arnaud Rosier in 2016, now serves as Chief Innovation Officer. Under his leadership, the company has developped innovative AI algorithms based on cardiac data. The company is now the European leader in telemonitoring of implantable cardiac devices and remote patient monitoring. In 2022, they raised a 21m euros Serie A. Aligned with Resolve Stroke’s ambition, David brings his visionary approach to data management in the healthcare industry.